Skip to main content

PRELUDE CAPITAL MANAGEMENT, LLC

Position in JNJ — Johnson & Johnson

CIK 1387508 NEW YORK, NY

Position in JNJ

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$347,938
-$97,832 QoQ
Shares Held
1,370
-36.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#4,032
of 4,664 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in JNJ Over Time

Shares Held

Position Value (USD)

Derivatives in JNJ

reported options exposure · as of Mar 31, 2025
CallValue
$1,326,720
CallShares
8,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

PRELUDE CAPITAL MANAGEMENT, LLC holds $9,540,290 across 6 Drug Manufacturers - General names. JNJ ranks #5 (3.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 JNJ
Johnson & Johnson
This page
1,370 $347,938

All Filings in JNJ

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $347,938 1,370
2025-12-31 $445,770 2,154
2025-09-30 $866,096 4,671
2025-06-30 $792,772 5,190
2025-03-31 $651,419 3,928
2025-03-31 $1,326,720 8,000
2024-12-31 $454,396 3,142
2024-09-30 $3,581,201 22,098
2024-06-30 $495,482 3,390
2024-03-31 $1,684,565 10,649
2022-03-31 $827,486 4,669
2021-12-31 $770,841 4,506
2021-09-30 $1,632,280 10,107
2021-06-30 $3,386,560 20,557
2021-03-31 $838,185 5,100
2021-03-31 $2,774,228 16,880
2020-12-31 $251,808 1,600
2020-12-31 $943,335 5,994
2020-09-30 $534,628 3,591
2020-06-30 $1,021,817 7,266
2020-06-30 $2,643,844 18,800
2020-03-31 $52,452 400
2020-03-31 $563,859 4,300